CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML
Conditions
Refractory Acute Myeloid Leukemia (AML) · Relapsed Acute Myeloid Leukemia (AML) · Myelodysplastic Syndrome · AML (Acute Myeloid Leukemia)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Colorado Hospital, Aurora, Colorado, United States
Study leads
Mathew Angelos, MD, PhD
Principal Investigator
University of Colorado, Denver